MedPath

ltrasound guided intercostal nerve block using pulsed radiofrequency in management of thoracic postherpetic neuralgia

Not Applicable
Completed
Conditions
post-herpetic neuralgia
Anaesthesiology - Pain management
Neurological - Other neurological disorders
Registration Number
ACTRN12614000941662
Lead Sponsor
Mohamed Y. Makharita
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
50
Inclusion Criteria

Adult patients who had chest wall PHN at T2-T11 of more than 6 months duration, who had moderate and severe pain (VAS more than 30 mm).

Exclusion Criteria

patient refusal, patients with mild pain,Presence of psychiatric illness. and infection at site of injection. Patients with history of renal, hepatic diseases, coagulopathy, diabetes, steroid therapy, malignancies and patients taking chemo and/or radiotherapy will be excluded

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Patients will be evaluated for pain severity using Visual Analogue Scale (VAS), (100 mm unmarked line in which 0 equal no pain and 100 mm means worst pain imaginable)[before the block (basal), , every 2 weeks after the procedure for 6 months and every 1 month for another 6 months. ];Quality of life[Quality of life will be evaluated using self-evaluation questionnaires (SF-36) at 1, 3, 6 and 12 months]
Secondary Outcome Measures
NameTimeMethod
Analgesic consumption was assessed on a patient daily diary [before the block (basal), , every 2 weeks after the procedure for 6 months and every 1 month for another 6 months.]
© Copyright 2025. All Rights Reserved by MedPath